Wells Fargo’s Cellectar Biosciences, Inc. Series A Warrants CLRBZ Stock Holding History

Wells Fargo’s Portfolio CLRBZ Stock Details CLRBZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,000	Closed	-$3K	–	6624
2017 Q3	$3K	Buy	+5,000	New	+$2.93K	﹤0.01%	6124

Other funds holding CLRBZ

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wells Fargo's CLRBZ Position: Q4 2017 in Review

Wells Fargo sold out of Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) in Q4 2017, closing a stake of 5,000 shares — an estimated $3K sold.

Wells Fargo first reported a position in CLRBZ in Q3 2017 and held it in 1 quarter. The position peaked at $3K in Q3 2017. 1 fund tracked by Wall St. Rank holds CLRBZ as of Q4 2017.

Wells Fargo reported no remaining Cellectar Biosciences, Inc. Series A Warrants position as of Q4 2017 after selling out during the quarter.
Wells Fargo sold 5,000 Cellectar Biosciences, Inc. Series A Warrants shares in Q4 2017, an estimated $3K.
Wells Fargo first reported a position in Cellectar Biosciences, Inc. Series A Warrants in Q3 2017 and held it in 1 quarter.
Wells Fargo's Cellectar Biosciences, Inc. Series A Warrants position peaked at $3K in Q3 2017.
1 fund tracked by Wall St. Rank held Cellectar Biosciences, Inc. Series A Warrants as of Q4 2017.

Based on Wells Fargo's 13F filing for Q4 2017, filed 8 Feb 2018.